Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2025-12-25 @ 2:00 PM
NCT ID:
NCT02173392
Group ID:
EG001
Title:
(Treatment B Days 1-28 + Treatment A Days 29-56)
Description:
210 mg SC Brodalumab (2 Pre-filled Syringes \[1.0mL + 0.5mL, Treatment B Days 1-28\])" first, then "Brodalumab (Single 1.5mL Pre-filled Syringe, treatment A Days 29-56)
Brodalumab: Brodalumab is a large molecule for the treatment of inflammatory diseases
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
131
Other Number Affected:
39
Other Number At Risk:
131
Study:
NCT02173392
Results Section:
NCT02173392
Adverse Events Module:
NCT02173392